MKI67 and neoplasm: Furthermore, tumor volume and immunostaining for proliferation marker Ki67 decreased, whereas staining for vascularity marker, platelet and endothelial cell adhesion molecule 1 (PECAM1; alias, CD31) remained unchanged.